ZNF785 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.834000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.074600E-01
Normal-vs-Stage2
5.195800E-01
Normal-vs-Stage3
4.986300E-02
Normal-vs-Stage4
9.392200E-01
Stage1-vs-Stage2
9.143900E-02
Stage1-vs-Stage3
6.320200E-03
Stage1-vs-Stage4
5.236400E-01
Stage2-vs-Stage3
4.738300E-02
Stage2-vs-Stage4
5.336400E-01
Stage3-vs-Stage4
5.619600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.281600E-01
Normal-vs-AfricanAmerican
4.588000E-01
Normal-vs-Asian
3.705800E-01
Caucasian-vs-AfricanAmerican
4.726600E-01
Caucasian-vs-Asian
3.601400E-01
AfricanAmerican-vs-Asian
9.765200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.471200E-01
Normal-vs-Female
5.270200E-01
Male-vs-Female
3.836000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.962600E-01
Normal-vs-Age(41-60Yrs)
8.000600E-01
Normal-vs-Age(61-80Yrs)
5.013400E-01
Normal-vs-Age(81-100Yrs)
3.941800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.719600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.539220E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.058590E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.023160E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.934450E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.200800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.698400E-01
Normal-vs-Daily Drinker
4.175000E-01
Normal-vs-Weekly Drinker
5.432600E-01
Normal-vs-Occasional Drinker
8.092000E-01
Normal-vs-Social Drinker
7.564000E-01
Non Drinker-vs-Daily Drinker
9.401600E-01
Non Drinker-vs-Weekly Drinker
8.356600E-01
Non Drinker-vs-Occasional Drinker
3.110000E-01
Non Drinker-vs-Social Drinker
6.851700E-02
Daily Drinker-vs-Weekly Drinker
8.130600E-01
Daily Drinker-vs-Occasional Drinker
3.476600E-01
Daily Drinker-vs-Social Drinker
5.599800E-02
Weekly Drinker-vs-Occasional Drinker
5.528800E-01
Weekly Drinker-vs-Social Drinker
1.486820E-01
Occasional Drinker-vs-Social Drinker
3.286200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.139630E-01
Normal-vs-Grade 2
9.836300E-03
Normal-vs-Grade 3
2.021900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.892200E-01
Grade 1-vs-Grade 3
2.591200E-01
Grade 1-vs-Grade 4
1.139630E-01
Grade 2-vs-Grade 3
5.464500E-02
Grade 2-vs-Grade 4
9.836300E-03
Grade 3-vs-Grade 4
2.021900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.017400E-01
Normal-vs-NonDiabetic
6.906800E-01
Diabetic-vs-NonDiabetic
1.912410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.260000E-01
Normal-vs-NoPancreatitis
5.009400E-01
Pancreatitis-vs-NoPancreatitis
2.588400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.556600E-01
Normal-vs-N1
4.497800E-01
N0-vs-N1
1.466960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.849400E-01
Normal-vs-TP53-NonMutant
9.287200E-01
TP53-Mutant-vs-TP53-NonMutant
3.507800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
